Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China
· Delayed Price · Currency is CNY 90.59
+1.83 (2.06%)
Apr 2, 2025, 1:45 PM CST
SHA:688578 Revenue
In the year 2024, Shanghai Allist Pharmaceuticals had annual revenue of 3.56B CNY with 76.29% growth. Shanghai Allist Pharmaceuticals had revenue of 1.02B in the quarter ending December 31, 2024, with 52.79% growth.
Revenue
3.56B
Revenue Growth
+76.29%
P/S Ratio
11.24
Revenue / Employee
3.41M
Employees
1,044
Market Cap
39.94B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |